Thomas Strack, MD, Named CMO at Faeth Therapeutics

Faeth Therapeutics, a healthcare company developing machine learning-driven precision nutrition solutions and therapeutic regimens to treat cancer, announced the appointment of Endocrine Society member Thomas Strack, MD, as chief medical officer.

Strack brings more than 29 years of biopharmaceutical industry and has led all phases of clinical development. Strack previously served as senior vice president, Clinical Development, at Molecular Templates, a publicly traded biopharmaceutical company where he was responsible for first-in-human trials in patients with solid and hematological tumors. He was also vice president, Clinical Development, at Progenics, and an executive at Asubio where was responsible for first-in-human trials targeting CNS diseases. Strack also held executive positions at Takeda, Pfizer, and Eli Lilly and Company.

Strack earned his medical doctorate from the University in Mainz, Germany, where he completed his internal medicine and endocrinology residencies, with additional postdoctoral research at the Hospital for Sick Children in Toronto, Canada. He has authored numerous scientific and clinical publications.

You may also like

  • Webinar Will Examine Concerns Around Compounding Anti-Obesity Medications

    Endocrine Society to host virtual Science Writers Conference Nov. 14 Surging demand for a new generation of highly effective anti-obesity medications is creating interest in compounded versions of these medications. Endocrine Society experts will discuss the importance of prescribing FDA-approved medications to treat obesity during the Society’s Virtual Science Writers Conference on November 14. What:…

  • Bianco Named Vice President and Vice Provost for Research, Chief Research Officer at UTMB

    Antonio Bianco, MD, PhD, has joined the University of Texas Medical Branch (UTMB) as vice president and vice provost, research, and chief research officer, effective Sept. 1. A renowned physician-scientist, scholar, and research leader, Bianco possesses an impressive academic career that includes influential contributions to the field of thyroid diseases and an enduring commitment to…

Find more in